---
title: "Krystal Biotech (KRYS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KRYS.US/norm.md"
symbol: "KRYS.US"
name: "Krystal Biotech"
parent: "https://longbridge.com/en/quote/KRYS.US.md"
datetime: "2026-05-21T21:40:57.866Z"
locales:
  - [en](https://longbridge.com/en/quote/KRYS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KRYS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KRYS.US/norm.md)
---

# Krystal Biotech (KRYS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 1.83 | 1.70 | 2.66 | 1.29 | 1.20 |
| ROE | 17.92% | 17.44% | 29.14% | 15.14% | 14.80% |
| Revenue | 116.36M | 107.11M | 97.80M | 96.04M | 88.18M |
| Net income | 55.93M | 51.40M | 79.36M | 38.33M | 35.73M |
| Operating income | 53.69M | 44.27M | 41.37M | 39.31M | 36.25M |
| Gross margin | 94.57% | 93.85% | 95.64% | 92.54% | 94.30% |
| Net margin | 48.07% | 47.99% | 81.15% | 39.91% | 40.52% |
| Profit quality | 66.79% | 57.12% | 104.32% | 74.55% | 117.06% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.40B | 1.33B | 1.24B | 1.14B | 1.07B |
| Leverage | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 |
| BVPS | 43.37 | 41.78 | 39.26 | 35.97 | 34.07 |
| Turnover | 0.3377 | 0.3257 | 0.3358 | 0.3494 | 0.3460 |
| Cash & STI | 823.40M | 827.79M | 731.07M | 681.99M | 616.85M |
| Inv & Rec | 42.65M | 40.48M | 37.63M | 31.04M | 29.94M |
| LT assets | 160.62M | 158.01M | 156.32M | 158.04M | 158.93M |
| Net debt | -1.01B | -946.52M | -854.67M | -811.11M | -755.66M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 80.38M | 77.51M | 39.66M | 52.73M | 30.97M |
| Investing CF | -63.58M | 11.16M | -4.29M | -10.53M | -54.77M |
| Financing CF | -10.46M | 15.67M | 3.71M | 1.80M | -12.47M |
| Free CF | 46.05M | 49.43M | 6.89M | 35.03M | 2.49M |
| OCF coverage | 1124.54% | 3623.56% | 2327.41% | 2769.38% | 499.18% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -7.15M | -2.14M | -1.70M | -1.90M | -6.20M |